PULLACH, Germany, March 19, 2014 /PRNewswire/ --
As a globally leading healthcare company, Linde Healthcare is dedicated to research and innovative developments. The REALfund supports purposeful solutions within respiratory medicine that benefit patients and caregivers alike. For further information and to apply, visit the REALfund website at http://www.linde-healthcare-realfund.com.
With the REALfund, Linde Healthcare, a global business unit of The Linde Group, addresses anyone working in the field of respiratory diseases and related co-morbidities to submit their ideas and apply for funding for their research work. Whether you are an academic researcher, physician, nurse, technician, industrial designer or active in a patient organisation, projects with the potential to develop better respiratory care solutions are welcome. Throughout the care continuum from hospital to home - the REALfund supports ideas that improve the quality of care and life of patients, help doctors or medical staff, relieve pressure on healthcare facilities or optimise health economics. Relevant projects will be funded with up to EUR 75,000 depending on their complexity. To be considered for the next funding period, applications can be submitted until 30 June 2014. The decision on grants will be taken following a thorough review process involving medical and scientific experts and the grantees will be honoured on 8 September 2014 in Munich, Germany.
Dr Christian Wojczewski, Head of Linde Healthcare, states: "For us, the interaction with medical communities and scientific societies is extremely important in helping make bright new ideas become 'real'. Our REALfund supports researchers in transforming their ideas into daily practice for the benefit of healthcare professionals and patients alike."
As healthcare systems are faced with heavy cost pressure, innovation in Healthcare as a whole becomes increasingly important. The REALfund proves Linde Healthcare's commitment towards improving standards of care and continues the fruitful history of the company's cooperation with researchers in hospitals and universities around the world.
About Linde Healthcare
Linde Healthcare is a globally leading healthcare company specialising along an integrated respiratory care path. Linde Healthcare combines pharmaceutical gases, medical devices, services and clinical care into purposeful solutions for patients and healthcare professionals throughout the care continuum from hospital to home. The company is present in over 60 countries and generated revenue of EUR 2.961 billion in 2012. Its product and service offering encompasses a wide range of product-oriented services such as gas supply and gas therapies, sleep and pain therapies, and patient-centred services. Linde Healthcare focuses on four strategic business segments: Hospital Care, Gas Therapies, Homecare and Care Concepts. Long known for expertise in respiratory homecare, our Homecare competencies cover the full spectrum of services with a focus on patients' individual needs. In the Care Concepts business segment, REMEO® is Linde Healthcare's innovative programme for long-term mechanically ventilated patient care, offering an integrated care path that bridges the gap between a hospital's ICU and a patient's home.
About The Linde Group
The Linde Group is a world-leading gases and engineering company with around 63,000 employees in more than 100 countries worldwide. In the 2012 financial year, Linde generated revenue of EUR 15.280 billion. The strategy of the Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations across the globe. The company is committed to technologies and products that unite the goals of customer value and sustainable development.
For more information, see The Linde Group online at http://www.linde.com
Anne Mette Schrade